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lance AR in CAP to provide information for judicious antibiotic
use for the containment of AR.
Methods: A cross-sectional observational study was carried out in
patients hospitalized with CAP. Patients were identiﬁed through
daily visits to emergency and medicine wards and were followed
from day of admission till the day of discharge from hospital.
Severity of disease was assessed with help of severity assessment
scales like PSI. The rates of AR were analyzed with help of
WHO.net 5.4 software.
Results: The most common pathogen isolated causing CAP were
S. pneumoniae 31 (25.62%), K. pneumonia 24 (19.83%), H. in-
ﬂuenza 18 (14.87%), S. aureus 16 (13.22%), P. aeruginosa 14
(6.7%), and M. pneumoniae 7 (5.9%). S. pneumoniae resistance
was high for penicillin (PEN) (45%), cefazoline (CZO) (40%), and
erythromycin (ERY) (39%) with low resistance for ciproﬂoxacin
(CIP) (8%) and oﬂoxacin (OFX) (14%).
K. pneumoniae resistance was high for ampicillin (AMP) (81%)
with good susceptibility to imipenam (IPM) (100%), chloram-
phenicol (CHL) (90%), gentamicin (GEN) (87%). H. inﬂuenzae had
high resistance for ERY while susceptibility was good (above 85%)
for antibiotics like (GEN, CIP, IPM.)
Conclusion: S. pneumoniae was found to be most common
pathogen in CAP. Incidence of gram negative pathogens (K.
pneumoniae, P. aeruginosa) causing CAP was high. Infection by
resistant pathogen had impact both on severity of disease and
outcome.
PP-179 Preparation of overlapping peptides of human
being’ SARS virus M protein and its application as
diagnose SARS
Dana Huang*, Yijie Geng, Renli Zhang. Shenzhen Center for
Diseases Control and Prevention
Objective: Preparation of overlapping peptides of human being’
SARS Virus M protein to diagonose SARS with linear B cell epitopes
of human being’ SARS Coronavirus M protein.
Methods: Analyze the hydrophilicity of Coronavirus M protein of
human being’ SARS using Genetyx-MAC9.0 soft. 164 overlapping
pepetides spanning of 6-mer were synthesized in the hydrophilic-
ity area with Auto-spot Robot. Taking a reaction of Dot-ElISA uses
the serum of 15 SARS patients and composing peptide chain.
Results: Several overlapping pepetides showed positve binding
with 15 patients with SARS, and ﬁve peptides seemed to be com-
mon epitope peptides. They are MKY1 (Gln-Len-Len-Gln-Gln-Trp-
Asn-Len-Val), MKY2 (Trp-Ph-Asn-Pro-Glu-Thr-Asn-Ile), MKY3 (Val-
Thr-Arg-Pro-Leu-Met-Glu-Ser), MKY4 (Ser-Tyr-Tyr-Lys-Leu-Gly-
Ala), MKY5 (Val-Gly-Thr-Asp-Ser-Gly-Phe-Ala-Ala-Tyr), sera did
not react with a control peptides, and normal sera also did not re-
act with pepetides of human being’ SARS Coronavirus M protein.
Conclusion: Taken together, these results point to linear B cell
epitopes of human being’ SARS Coronavirus M protein could
diagnose patients of SARS.
PP-180 Elaboration of viral vaccine delivery
Elena Nechaeva*, Nikolay Varaksin, Tatyana Ryabicheva,
Tatyana Sen’kina, Natalia Gilina, Tatyana Sviridenko,
Raisa Martinyuk. SRC VB Vector
Elaboration of mucosal vaccines involving biodegradable polymer
complexes is a topical problem. These polymers are capable of
protecting the virus from acid gastric medium and releasing the
virus in weakly alkaline intestinal medium. In addition, the ma-
jority of these polymers are capable of intensifying the immune
response to the antigen introduced.
The purpose of work was the choice of the polymer system for
effective viral vaccine development.
We used the following methods:
– microgranulation into a polymer matrix through atomization
of the viral material dissolved in polymeric solvent into a
liquid nitrogen,
– microencapsulation through forming the coating on a drop
containing the viral material, while contacting with solution
of the forming material,
– micro- and nanoencapsulation by cryocoacervation method.
– coacervation of viral suspensions in hydrophobic liquids into a
gelatin envelope.
The methods of transmission electron microscopy, atomic force
microscopy, freeze-fractography, determination of speciﬁc activ-
ity and immunogenicity were used to control of viral prepara-
tions.
According to our data, the most perspective method was the
cryocoacervation. The method proposed allows for production
of spherical or irregular-shaped particles with size of 0.1-10
μm. This method is universal and may be applied for micro-
and nanoencapsulation of different viruses and for design of
various viral vaccines. International PCT patent application was
submitted and registered as PCT/Ru/02/00465.
PP-181 A novel 2-tailed CUSUM control-chart for
evaluating new therapies: hypertonic-saline in
bronchiolitis compared to nebulized adrenaline
Neeraj Gupta*, Jacob Puliyel, Ashutosh Shrivastava,
Samiksha Manchanda. St. Stephen’s Hospital
Background: Randomized control trials are difﬁcult to perform,
expensive and involve thorny ethical issues. CUSUM is a contin-
uous process of monitoring, used in industry that allows early
detection of deviations from the norm. We used CUSUM to study
3% saline nebulization (3%SN), a new treatment for bronchiolitis.
The response rate to standard therapy with nebulized adrenaline
(STNA) provided parameters within which 3% SN was evaluated.
Methods: Children 2 months to 2 years admitted with ﬁrst
episode acute bronchiolitis were recruited. In phase-one, STNA
was studied looking for improvement or deterioration on Downes
respiratory-distress-score. Downes score at admission could im-
prove or deteriorate during course of treatment. This provided
the stopping rule and also the thresholds beyond which 3% SN
can be considered as yielding more improvement than standard
therapy. A total of 35 children were enrolled in phase 1 and 28
received 3% SN in phase 2.
Results: The probability of deterioration with 3% SN was half
(1:14) compared to STNA (1:7) and 89.3% showed improve-
ment compared to 82.8%. Plotting these in sequence on the
CUSUM-chart allowed for continued use of the new therapy and
conﬁdence that it was not inferior to standard therapy.
Conclusion: Changes in score with treatment allowed the CUSUM-
graph to depict if the new intervention produced more adverse
events (crossing stopping threshold) or was signiﬁcantly better.
We found that 3% SN children had less deterioration than STNA
and there was a trend for more improvement. CUSUM, as we have
employed it, has potential in numerous medical evaluations.
PP-182 Systematic study the clinic characters of a local
measles outbreak in East China
Tiansheng Xie*,1, Nanping Wu1, Airong Hu2, Xiaoyue Liang2.
1State Key Laboratory for Infectious Disease Diagnosis and
Treatment, The First Afﬁliated Hospital, College of Medical
Sciences, Zhejiang University, Hangzhou, Zhejiang, China;
2Ningbo Infectious Diseases Hospital, Ningbo, Zhejiang, China
Background: EPI has obviously decreased the incidence of
measles, recently years locally outbreak still presence with
some new clinical features, all of these bring new challenges to
measles elimination.
Methods: We collected the clinical information detailed. 216
patients were divided into three groups: infants, children and
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adult. Withdrawal the acute phase serum, we ﬁnished the blood
routine, hepatic function and IgM antibody test. In adult group
we detected the T lymphocytes sub-type using ﬂow cytometry.
Results: 216 patients’ infectious spectrum was like a spindle,
the infants and adults parts of the infectious spectrum reach a
total of 81.48%. The clinical symptoms remain relatively typical.
Different groups showed their own clinical manifestations, The
major features of the infants group are cough and Korotkoff
plaques, in this group, the MV-IgM positive rate is the highest,
83.67% of the infants have complications. The subjects of the
children group showed the major symptoms as catarrhal, 70% of
which with complications. Hepatic function in the adult group is
signiﬁcantly abnormal. In our 78 cases adult patients, the FCM
results suggest CD4 cell count and CD4/CD8 decreased signiﬁ-
cantly, and CD8 increased signiﬁcantly, also CD4 + CD45RA + was
signiﬁcantly lower than control (p<0.05), and CD8 + CD45RO +
was signiﬁcantly higher than control group (p<0.05).
Conclusion: The use of measles vaccine greatly change its infec-
tious spectrum. The emergence of new clinical characteristics
give us challenges for its prevention and control. At the same
time, further study of the measles infectious cellular immunity
mechanism still needed.
PP-183 Prevalence of pneumonia cases during the Hajj
season
Atif Asghar*,1, Ahmad Ashshi 1, Aiman Momenah1, Tariq Zafar 1,
Esam Azhar2, Syed Bukhari 3. 1Umm Al-Qura University; 2King
Abdulaziz University; 3Herra Genaral Hospital
Background: The congregation of so many people during Hajj
seasons from different parts of the world in unavoidably over-
crowded conditions within a conﬁned area for a deﬁned period of
time presents many public health challenges, and health risks are
greatly increased. One of the main health problems correlated
with Hajj crowding is pneumonia due to its ease of transmission
by air droplets.
Method: A total of 92 suspected patients with pneumonia from
the three main tertiary hospitals in Makkah were investigated
during the 2005 Hajj season. Sputum and serum samples were
collected and investigated for possible presence of typical or
atypical causative agents using the standard identiﬁcation tech-
niques.
Results: Clinically, most of the patients came with typical pneu-
monia symptoms. More than 60% of the patients were above 60
years old and 58% were men. The most frequent isolates were
Candida spp, (27%) followed by Pseudomonas aeruginosa (20.7%)
and Legionella pneumophila (14.1%). Interestingly, more than
causative pathogen were isolated in 15 patients (16.3%). A 55%
of patients were diabetic.
Conclusion: Clinicians should be aware that typical pneumonia
treatment regimes may not work well during the Hajj season
due to the wide variety of isolated organisms. This necessitates
taking a sputum sample before starting treatment for identiﬁ-
cation and sensitivity testing. Since most of the patients are
above 60 years, a special concern should be given to this age
group which include; immunization, avoiding crowding and using
a facial masks to reduce the chance of infection.
PP-184 Clinical characteristics and detection of human
bocavirus in hospitalized children with acute
lower respiratory tract infection in China
Guo-cheng Zhang*, Xue-houg Zhang, Xiao-jing Nie,
Dong-liang Xu, Biao Li. Department of Pediatrics, Xijing
Hospital, Fourth Military Medical University, Xi’an, China
Background: The newly identiﬁed human bocavirus (HBoV), a
member of the Parvoviridae family, has been associated to low
respiratory tract infections in young children.
Objective: To analyze clinical characteristics of HBoV infection
through detection of HBoV DNA in Sputum and serum in pediatric
patients with acute lower respiratory tract infection (ALRTI) in
Xi’an, China.
Methods: Sputum and acute-phase serum were collected from
228 children less than 14 years old admitted for ALRTI between
January 2008 and January 2009 at the Department of paediatrics,
of Xijing Hospital. sputum was used for HBoV DNA extraction and
detection of common respiratory viruses. In addition, Sputum and
acute-phase and convalescent-phase serum samples of children
with positive hBoV DNA in Sputum were also tested for HBoV DNA
and PVB19 DNA if they were obtained. Clinical characteristics of
HBoV infection were analyzed. The HBoV infections with other
respiratory viruses and PVB19 were also analyzed. PCR products
with expected molecular mass was selected for DNA sequencing
and were compared with the sequences of HBoV in the GenBank
with clustalW software.
Results: HBoV was found in 14 (6.1%) samples. Infections with
HBoV were most occurred in the winter and spring months.
73.3% of patients with HBoV infection were aged 6 months to
3-year-old.In common with other respiratory viruses infection,
clinical manifestations included cough, fever, wheezing, diar-
rhea, hypoxia and length of stay. In 6 (42.9%) of the HBoV
positive children, co-infections with other respiratory viruses
were present. HBoV infections with other respiratory viruses
and PVB19 were clinically similar to single infections except the
wheezing, hypoxia and length of stay. The sequenced product
(291bp) shared high nucleotide sequence homology (99.6%) with
the prototype Stockholm 2 (st2, No. DQ00496) and two Beijing
strains (No. DQ988934.2 and No. DQ988933.1) when compared
with their sequences. Both HBoV DNA and PVB19 DNA were not
detected in either sputum or the acute- and convalescent-phase
serum of 14 patients whose sputum was positive for HBoV as
determined by PCR.
Conclusions: HBoV is found in sputum of hospitalized for ALRTI in
14 children, children with HBoV infections with other respiratory
viruses and PVB19 were prone to have wheezing, hypoxia and
more days hospitalized.
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PP-185 A health systems approach to managing and
integrating STI services in Cape Town, South
Africa
Vera Scott, Feroza Amien*. University of the Western Cape
Background: In Cape Town, a metropolitan area in South Africa,
programme and facility managers are committed to improving
the effectiveness and integration of the STI programme. This is
achieved with annual evaluations.
Methods: A standardized evaluation tool has been used: a review
of routine information; a facility manager interview to assess
availability of services and staff training; an inspection checklist
to assess whether consulting rooms are appropriately equipped
to support quality syndromic management consultations; a folder
review to assess quality and integration of client care. Audit
teams are made up of facility and programme managers.
Results: In October 2008, 146 health facilities and all their facil-
ity managers participated, and 1199 STI folders were reviewed
(see Table 1, p. S99).
Conclusion: These results provide primary level facility man-
agers with useful information to strengthen programme delivery
in facilities, the key level of implementation. There are still
missed opportunities in targeting STI consultations for further
HIV prevention work.
